aluates Reports

$ 0.0

Automative

Global Lipid Nanoparticle (LNP) Formulation Service Market Research Report 2026

Published Date: 2026-04-29

Report Code: QYRE-Auto-35T18954

Global Lipid Nanoparticle LNP Formulation Service Market Research Report 2025

BUY CHAPTERS

Global Lipid Nanoparticle (LNP) Formulation Service Market Research Report 2026

Code: QYRE-Auto-35T18954

Report

2026-04-29

Pages:132

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GenScript

Creative-Biolabs

Cytiva

WuXi STA

Croda International

MicroNano Biologics

Precigenome

Evonik

Genevant Sciences

Nippon Fine Chemical

Lipid Nanoparticle (LNP) Formulation Service Market Size

The global Lipid Nanoparticle (LNP) Formulation Service market was valued at US$ 553 million in 2025 and is anticipated to reach US$ 1235 million by 2032, at a CAGR of 12.3% from 2026 to 2032.

Lipid Nanoparticle (LNP) Formulation Service Market

LNPs (Lipid Nanoparticles) are a novel potential delivery tool in the 100-150 nanometer range, serving as an important alternative to polymer systems. LNPs are lipophilic substances that have been shown to effectively deliver nucleic acid-based therapeutic products. This delivery system utilizes biocompatible lipid materials as carriers, capable of dissolving, encapsulating, adsorbing, and attaching drugs or other bioactive substances. Compared to other delivery systems, LNPs offer numerous advantages, including enhanced drug absorption, modified drug toxicity, improved drug stability, and controlled drug release. As a result, LNPs play an increasingly important role in the delivery of gene therapies, anticancer drugs, proteins, and peptides.

Driven by the expanding pipeline of RNA therapeutics—including mRNA vaccines, siRNA drugs, and gene editing modalities—demand for LNP formulation services has surged across both early discovery and late-stage clinical development. The market is increasingly dominated by integrated CDMO providers with end-to-end capabilities in lipid synthesis, formulation optimization, scale-up, and GMP manufacturing. Leading players such as WuXi STA, Merck, and Evonik are capturing global demand through platform-based offerings and commercial-scale capacity. The sector is witnessing dual consolidation: top-tier CDMOs are gaining share via one-stop service models, while proprietary LNP delivery platforms remain concentrated among a few with ionizable lipid expertise and high encapsulation efficiency. Despite rapid growth, high raw material costs and complex process validation remain key bottlenecks. Future cost compression is expected through modular manufacturing, in-house lipid production, and standardized LNP platforms. Chinese firms are rapidly scaling up their capabilities to serve both domestic nucleic acid innovators and global mRNA vaccine export projects, with select players poised to become competitive globally.

This report delivers a comprehensive overview of the global Lipid Nanoparticle (LNP) Formulation Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lipid Nanoparticle (LNP) Formulation Service. The Lipid Nanoparticle (LNP) Formulation Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Lipid Nanoparticle (LNP) Formulation Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Lipid Nanoparticle (LNP) Formulation Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Lipid Nanoparticle (LNP) Formulation Service Market Report

Report Metric	Details
Report Name	Lipid Nanoparticle (LNP) Formulation Service Market
Accounted market size in 2025	US$ 553 million
Forecasted market size in 2032	US$ 1235 million
CAGR	12.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	mRNA-lipid Nanoparticle siRNA-lipid Nanoparticle Other
Segment by Application	Gene Therapy Vaccine Cancer Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cytiva, Croda International, Evonik, Merck KGaA, Genevant Sciences, Nippon Fine Chemical, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, GenScript, WuXi STA, MicroNano Biologics, Precigenome, Catalent, Wacker
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Lipid Nanoparticle (LNP) Formulation Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Lipid Nanoparticle (LNP) Formulation Service Market growing?

Ans: The Lipid Nanoparticle (LNP) Formulation Service Market witnessing a CAGR of 12.3% during the forecast period 2026-2032.

What is the Lipid Nanoparticle (LNP) Formulation Service Market size in 2032?

Ans: The Lipid Nanoparticle (LNP) Formulation Service Market size in 2032 will be US$ 1235 million.

Who are the main players in the Lipid Nanoparticle (LNP) Formulation Service Market report?

Ans: The main players in the Lipid Nanoparticle (LNP) Formulation Service Market are Cytiva, Croda International, Evonik, Merck KGaA, Genevant Sciences, Nippon Fine Chemical, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, GenScript, WuXi STA, MicroNano Biologics, Precigenome, Catalent, Wacker

What are the Application segmentation covered in the Lipid Nanoparticle (LNP) Formulation Service Market report?

Ans: The Applications covered in the Lipid Nanoparticle (LNP) Formulation Service Market report are Gene Therapy, Vaccine, Cancer Treatment

What are the Type segmentation covered in the Lipid Nanoparticle (LNP) Formulation Service Market report?

Ans: The Types covered in the Lipid Nanoparticle (LNP) Formulation Service Market report are mRNA-lipid Nanoparticle, siRNA-lipid Nanoparticle, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 mRNA-lipid Nanoparticle

1.2.3 siRNA-lipid Nanoparticle

1.2.4 Other

1.3 Market by Application

1.3.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Gene Therapy

1.3.3 Vaccine

1.3.4 Cancer Treatment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Perspective (2021–2032)

2.2 Global Lipid Nanoparticle (LNP) Formulation Service Growth Trends by Region

2.2.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Lipid Nanoparticle (LNP) Formulation Service Historic Market Size by Region (2021–2026)

2.2.3 Lipid Nanoparticle (LNP) Formulation Service Forecasted Market Size by Region (2027–2032)

2.3 Lipid Nanoparticle (LNP) Formulation Service Market Dynamics

2.3.1 Lipid Nanoparticle (LNP) Formulation Service Industry Trends

2.3.2 Lipid Nanoparticle (LNP) Formulation Service Market Drivers

2.3.3 Lipid Nanoparticle (LNP) Formulation Service Market Challenges

2.3.4 Lipid Nanoparticle (LNP) Formulation Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lipid Nanoparticle (LNP) Formulation Service Players by Revenue

3.1.1 Global Top Lipid Nanoparticle (LNP) Formulation Service Players by Revenue (2021–2026)

3.1.2 Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Lipid Nanoparticle (LNP) Formulation Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Lipid Nanoparticle (LNP) Formulation Service Revenue

3.4 Global Lipid Nanoparticle (LNP) Formulation Service Market Concentration Ratio

3.4.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lipid Nanoparticle (LNP) Formulation Service Revenue in 2025

3.5 Global Key Players of Lipid Nanoparticle (LNP) Formulation Service Head Offices and Areas Served

3.6 Global Key Players of Lipid Nanoparticle (LNP) Formulation Service, Products and Applications

3.7 Global Key Players of Lipid Nanoparticle (LNP) Formulation Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Lipid Nanoparticle (LNP) Formulation Service Breakdown Data by Type

4.1 Global Lipid Nanoparticle (LNP) Formulation Service Historic Market Size by Type (2021–2026)

4.2 Global Lipid Nanoparticle (LNP) Formulation Service Forecasted Market Size by Type (2027–2032)

5 Lipid Nanoparticle (LNP) Formulation Service Breakdown Data by Application

5.1 Global Lipid Nanoparticle (LNP) Formulation Service Historic Market Size by Application (2021–2026)

5.2 Global Lipid Nanoparticle (LNP) Formulation Service Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Lipid Nanoparticle (LNP) Formulation Service Market Size (2021–2032)

6.2 North America Lipid Nanoparticle (LNP) Formulation Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2021–2026)

6.4 North America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size (2021–2032)

7.2 Europe Lipid Nanoparticle (LNP) Formulation Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2021–2026)

7.4 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Market Size (2021–2032)

8.2 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size (2021–2032)

9.2 Latin America Lipid Nanoparticle (LNP) Formulation Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2021–2026)

9.4 Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size (2021–2032)

10.2 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cytiva

11.1.1 Cytiva Company Details

11.1.2 Cytiva Business Overview

11.1.3 Cytiva Lipid Nanoparticle (LNP) Formulation Service Introduction

11.1.4 Cytiva Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.1.5 Cytiva Recent Development

11.2 Croda International

11.2.1 Croda International Company Details

11.2.2 Croda International Business Overview

11.2.3 Croda International Lipid Nanoparticle (LNP) Formulation Service Introduction

11.2.4 Croda International Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.2.5 Croda International Recent Development

11.3 Evonik

11.3.1 Evonik Company Details

11.3.2 Evonik Business Overview

11.3.3 Evonik Lipid Nanoparticle (LNP) Formulation Service Introduction

11.3.4 Evonik Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.3.5 Evonik Recent Development

11.4 Merck KGaA

11.4.1 Merck KGaA Company Details

11.4.2 Merck KGaA Business Overview

11.4.3 Merck KGaA Lipid Nanoparticle (LNP) Formulation Service Introduction

11.4.4 Merck KGaA Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.4.5 Merck KGaA Recent Development

11.5 Genevant Sciences

11.5.1 Genevant Sciences Company Details

11.5.2 Genevant Sciences Business Overview

11.5.3 Genevant Sciences Lipid Nanoparticle (LNP) Formulation Service Introduction

11.5.4 Genevant Sciences Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.5.5 Genevant Sciences Recent Development

11.6 Nippon Fine Chemical

11.6.1 Nippon Fine Chemical Company Details

11.6.2 Nippon Fine Chemical Business Overview

11.6.3 Nippon Fine Chemical Lipid Nanoparticle (LNP) Formulation Service Introduction

11.6.4 Nippon Fine Chemical Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.6.5 Nippon Fine Chemical Recent Development

11.7 Polymun Scientific

11.7.1 Polymun Scientific Company Details

11.7.2 Polymun Scientific Business Overview

11.7.3 Polymun Scientific Lipid Nanoparticle (LNP) Formulation Service Introduction

11.7.4 Polymun Scientific Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.7.5 Polymun Scientific Recent Development

11.8 Corden Pharma

11.8.1 Corden Pharma Company Details

11.8.2 Corden Pharma Business Overview

11.8.3 Corden Pharma Lipid Nanoparticle (LNP) Formulation Service Introduction

11.8.4 Corden Pharma Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.8.5 Corden Pharma Recent Development

11.9 Acuitas Therapeutics

11.9.1 Acuitas Therapeutics Company Details

11.9.2 Acuitas Therapeutics Business Overview

11.9.3 Acuitas Therapeutics Lipid Nanoparticle (LNP) Formulation Service Introduction

11.9.4 Acuitas Therapeutics Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.9.5 Acuitas Therapeutics Recent Development

11.10 Creative Biolabs

11.10.1 Creative Biolabs Company Details

11.10.2 Creative Biolabs Business Overview

11.10.3 Creative Biolabs Lipid Nanoparticle (LNP) Formulation Service Introduction

11.10.4 Creative Biolabs Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.10.5 Creative Biolabs Recent Development

11.11 GenScript

11.11.1 GenScript Company Details

11.11.2 GenScript Business Overview

11.11.3 GenScript Lipid Nanoparticle (LNP) Formulation Service Introduction

11.11.4 GenScript Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.11.5 GenScript Recent Development

11.12 WuXi STA

11.12.1 WuXi STA Company Details

11.12.2 WuXi STA Business Overview

11.12.3 WuXi STA Lipid Nanoparticle (LNP) Formulation Service Introduction

11.12.4 WuXi STA Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.12.5 WuXi STA Recent Development

11.13 MicroNano Biologics

11.13.1 MicroNano Biologics Company Details

11.13.2 MicroNano Biologics Business Overview

11.13.3 MicroNano Biologics Lipid Nanoparticle (LNP) Formulation Service Introduction

11.13.4 MicroNano Biologics Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.13.5 MicroNano Biologics Recent Development

11.14 Precigenome

11.14.1 Precigenome Company Details

11.14.2 Precigenome Business Overview

11.14.3 Precigenome Lipid Nanoparticle (LNP) Formulation Service Introduction

11.14.4 Precigenome Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.14.5 Precigenome Recent Development

11.15 Catalent

11.15.1 Catalent Company Details

11.15.2 Catalent Business Overview

11.15.3 Catalent Lipid Nanoparticle (LNP) Formulation Service Introduction

11.15.4 Catalent Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.15.5 Catalent Recent Development

11.16 Wacker

11.16.1 Wacker Company Details

11.16.2 Wacker Business Overview

11.16.3 Wacker Lipid Nanoparticle (LNP) Formulation Service Introduction

11.16.4 Wacker Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

11.16.5 Wacker Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GenScript

Creative-Biolabs

Cytiva

WuXi STA

Croda International

MicroNano Biologics

Precigenome

Evonik

Genevant Sciences

Nippon Fine Chemical

List of Tables

Table 1. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of mRNA-lipid Nanoparticle

Table 3. Key Players of siRNA-lipid Nanoparticle

Table 4. Key Players of Other

Table 5. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (US$ Million), 2021–2026

Table 8. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Region (2021–2026)

Table 9. Global Lipid Nanoparticle (LNP) Formulation Service Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Region (2027–2032)

Table 11. Lipid Nanoparticle (LNP) Formulation Service Market Trends

Table 12. Lipid Nanoparticle (LNP) Formulation Service Market Drivers

Table 13. Lipid Nanoparticle (LNP) Formulation Service Market Challenges

Table 14. Lipid Nanoparticle (LNP) Formulation Service Market Restraints

Table 15. Global Lipid Nanoparticle (LNP) Formulation Service Revenue by Players (US$ Million), 2021–2026

Table 16. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Players (2021–2026)

Table 17. Global Top Lipid Nanoparticle (LNP) Formulation Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Lipid Nanoparticle (LNP) Formulation Service Revenue, 2025

Table 18. Ranking of Global Top Lipid Nanoparticle (LNP) Formulation Service Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Lipid Nanoparticle (LNP) Formulation Service Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Lipid Nanoparticle (LNP) Formulation Service, Headquarters and Area Served

Table 21. Global Key Players of Lipid Nanoparticle (LNP) Formulation Service, Products and Applications

Table 22. Global Key Players of Lipid Nanoparticle (LNP) Formulation Service, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (US$ Million), 2021–2026

Table 25. Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Type (2021–2026)

Table 26. Global Lipid Nanoparticle (LNP) Formulation Service Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Type (2027–2032)

Table 28. Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (US$ Million), 2021–2026

Table 29. Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Application (2021–2026)

Table 30. Global Lipid Nanoparticle (LNP) Formulation Service Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Application (2027–2032)

Table 32. North America Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (US$ Million), 2021–2026

Table 34. North America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (US$ Million), 2027–2032

Table 47. Cytiva Company Details

Table 48. Cytiva Business Overview

Table 49. Cytiva Lipid Nanoparticle (LNP) Formulation Service Product

Table 50. Cytiva Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 51. Cytiva Recent Development

Table 52. Croda International Company Details

Table 53. Croda International Business Overview

Table 54. Croda International Lipid Nanoparticle (LNP) Formulation Service Product

Table 55. Croda International Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 56. Croda International Recent Development

Table 57. Evonik Company Details

Table 58. Evonik Business Overview

Table 59. Evonik Lipid Nanoparticle (LNP) Formulation Service Product

Table 60. Evonik Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 61. Evonik Recent Development

Table 62. Merck KGaA Company Details

Table 63. Merck KGaA Business Overview

Table 64. Merck KGaA Lipid Nanoparticle (LNP) Formulation Service Product

Table 65. Merck KGaA Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 66. Merck KGaA Recent Development

Table 67. Genevant Sciences Company Details

Table 68. Genevant Sciences Business Overview

Table 69. Genevant Sciences Lipid Nanoparticle (LNP) Formulation Service Product

Table 70. Genevant Sciences Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 71. Genevant Sciences Recent Development

Table 72. Nippon Fine Chemical Company Details

Table 73. Nippon Fine Chemical Business Overview

Table 74. Nippon Fine Chemical Lipid Nanoparticle (LNP) Formulation Service Product

Table 75. Nippon Fine Chemical Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 76. Nippon Fine Chemical Recent Development

Table 77. Polymun Scientific Company Details

Table 78. Polymun Scientific Business Overview

Table 79. Polymun Scientific Lipid Nanoparticle (LNP) Formulation Service Product

Table 80. Polymun Scientific Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 81. Polymun Scientific Recent Development

Table 82. Corden Pharma Company Details

Table 83. Corden Pharma Business Overview

Table 84. Corden Pharma Lipid Nanoparticle (LNP) Formulation Service Product

Table 85. Corden Pharma Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 86. Corden Pharma Recent Development

Table 87. Acuitas Therapeutics Company Details

Table 88. Acuitas Therapeutics Business Overview

Table 89. Acuitas Therapeutics Lipid Nanoparticle (LNP) Formulation Service Product

Table 90. Acuitas Therapeutics Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 91. Acuitas Therapeutics Recent Development

Table 92. Creative Biolabs Company Details

Table 93. Creative Biolabs Business Overview

Table 94. Creative Biolabs Lipid Nanoparticle (LNP) Formulation Service Product

Table 95. Creative Biolabs Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 96. Creative Biolabs Recent Development

Table 97. GenScript Company Details

Table 98. GenScript Business Overview

Table 99. GenScript Lipid Nanoparticle (LNP) Formulation Service Product

Table 100. GenScript Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 101. GenScript Recent Development

Table 102. WuXi STA Company Details

Table 103. WuXi STA Business Overview

Table 104. WuXi STA Lipid Nanoparticle (LNP) Formulation Service Product

Table 105. WuXi STA Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 106. WuXi STA Recent Development

Table 107. MicroNano Biologics Company Details

Table 108. MicroNano Biologics Business Overview

Table 109. MicroNano Biologics Lipid Nanoparticle (LNP) Formulation Service Product

Table 110. MicroNano Biologics Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 111. MicroNano Biologics Recent Development

Table 112. Precigenome Company Details

Table 113. Precigenome Business Overview

Table 114. Precigenome Lipid Nanoparticle (LNP) Formulation Service Product

Table 115. Precigenome Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 116. Precigenome Recent Development

Table 117. Catalent Company Details

Table 118. Catalent Business Overview

Table 119. Catalent Lipid Nanoparticle (LNP) Formulation Service Product

Table 120. Catalent Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 121. Catalent Recent Development

Table 122. Wacker Company Details

Table 123. Wacker Business Overview

Table 124. Wacker Lipid Nanoparticle (LNP) Formulation Service Product

Table 125. Wacker Revenue in Lipid Nanoparticle (LNP) Formulation Service Business (US$ Million), 2021–2026

Table 126. Wacker Recent Development

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

Table 130. Authors List of This Report

List of Figures

Figure 1. Lipid Nanoparticle (LNP) Formulation Service Picture

Figure 2. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Type: 2025 vs 2032

Figure 4. mRNA-lipid Nanoparticle Features

Figure 5. siRNA-lipid Nanoparticle Features

Figure 6. Other Features

Figure 7. Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Application: 2025 vs 2032

Figure 9. Gene Therapy Case Studies

Figure 10. Vaccine Case Studies

Figure 11. Cancer Treatment Case Studies

Figure 12. Lipid Nanoparticle (LNP) Formulation Service Report Years Considered

Figure 13. Global Lipid Nanoparticle (LNP) Formulation Service Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Lipid Nanoparticle (LNP) Formulation Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Region: 2025 vs 2032

Figure 16. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Players in 2025

Figure 17. Global Lipid Nanoparticle (LNP) Formulation Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Lipid Nanoparticle (LNP) Formulation Service Revenue in 2025

Figure 19. North America Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Lipid Nanoparticle (LNP) Formulation Service Market Share by Country (2021–2032)

Figure 21. United States Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Lipid Nanoparticle (LNP) Formulation Service Market Share by Country (2021–2032)

Figure 25. Germany Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Market Share by Region (2021–2032)

Figure 33. China Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Lipid Nanoparticle (LNP) Formulation Service Market Share by Country (2021–2032)

Figure 41. Mexico Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Share by Country (2021–2032)

Figure 45. Israel Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Lipid Nanoparticle (LNP) Formulation Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Cytiva Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 49. Croda International Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 50. Evonik Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 51. Merck KGaA Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 52. Genevant Sciences Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 53. Nippon Fine Chemical Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 54. Polymun Scientific Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 55. Corden Pharma Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 56. Acuitas Therapeutics Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 57. Creative Biolabs Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 58. GenScript Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 59. WuXi STA Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 60. MicroNano Biologics Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 61. Precigenome Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 62. Catalent Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 63. Wacker Revenue Growth Rate in Lipid Nanoparticle (LNP) Formulation Service Business (2021–2026)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lipid Nanoparticle LNP Development Service Market Research Report 2025

Global Lipid Nanoparticle LNP Services Market Research Report 2025

Global LNP Synthesis System Market Research Report 2024

Global Lipid Nanoparticle LNP Production Equipment Market Research Report 2024

Global Lipid Nanoparticles LNP Market Research Report 2024

Global Lipid Nanoparticle LNP Synthesis Services Market Research Report 2025

Global Lipid Contract Manufacturing Market Research Report 2024

Global RNA LNP Lipid Nanoparticle Formulation Market Research Report 2024

Global Polymer Nanoparticles PNP Formulation Development Market Research Report 2024

Global Lipid Nanoparticle LNP Raw Material Market Research Report 2024

Global Lipid Nanoparticle Development Service Market Research Report 2024

Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Research Report 2024

Global Nanoparticle Drug Delivery Systems Market Research Report 2024

Global Lipid Nanoparticle CDMO Market Research Report 2025

Liposomal and Lipid based Nanoparticle Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lipid Nanoparticles LNPs CDMO Service Market Research Report 2024

Liposomal and Lipid Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liposome and Lipid Nanoparticle FDF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lipid Nanoparticle Synthesis System Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions